Leukemia, Myelodysplasia, Transplantation

Advice from the front lines: How cancer centers can cope with COVID-19

April 2, 2020

Maintaining cancer care in the face of COVID-19

April 1, 2020

Cancer care and COVID-19 in Seattle, the first U.S. epicenter

March 23, 2020

How is oncology adapting to COVID-19?

March 23, 2020

Disruptions in cancer care in the era of COVID-19

March 20, 2020

Glaring gap in CV event reporting in pivotal cancer trials

February 12, 2020

Survival for older AML patients better with HSCT from unrelated donors

February 8, 2020

Novel mutations contribute to progression of venetoclax-treated CLL

February 2, 2020

CAR T-cell therapy may worsen mental health in some patients

January 21, 2020

9/11 responders show increased risk of leukemia, other cancers

January 14, 2020

CAR T cells produce complete responses in T-cell malignancies

January 7, 2020

Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLL

December 10, 2019

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Gene signature may help guide initial CLL treatment choice

November 14, 2019